Novartis AG - Company & Market Research Reports

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.


Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
World In Vitro Diagnostics (IVD) Market Bundle: Molecular Diagnostics (Microbiology, Oncology, Blood, Prenatal, Inherited, Others), Cancer Diagnostics (HPV, ISH, Cytometry, PSA, FOB, Others), Infectious Diseases (ID/AST, POC, HAIs, STDs, Other) - Product Thumbnail Image

World In Vitro Diagnostics (IVD) Market Bundle: Molecular Diagnostics (Microbiology, Oncology, Blood, Prenatal, Inherited, Others), Cancer Diagnostics (HPV, ISH, Cytometry, PSA, FOB, Others), Infectious Diseases (ID/AST, POC, HAIs, STDs, Other)

  • Report
  • 2100 Pages
From
Afinitor 2016 U.S Promotional Report - Product Thumbnail Image

Afinitor 2016 U.S Promotional Report

  • Report
  • 30 Pages
From
IVD Procedure Volumes and Pricing Analysis - Product Thumbnail Image

IVD Procedure Volumes and Pricing Analysis

  • Report
  • 213 Pages
From
The World Market for Cancer Diagnostics, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays) - Product Thumbnail Image

The World Market for Cancer Diagnostics, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays)

  • Report
  • 861 Pages
From
The World Market for Molecular Diagnostics, 6th Edition (Microbiology, Oncology, Blood Screening and Typing, Prenatal, Inherited Diseases, Coagulation, Organ Transplant, PCR, Sequencing, cfDNA, CTC, in situ hybridization, Others) - Product Thumbnail Image

The World Market for Molecular Diagnostics, 6th Edition (Microbiology, Oncology, Blood Screening and Typing, Prenatal, Inherited Diseases, Coagulation, Organ Transplant, PCR, Sequencing, cfDNA, CTC, in situ hybridization, Others)

  • Report
  • 1032 Pages
From
Global Over The Counter Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin - Product Thumbnail Image

Global Over The Counter Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • Report
  • 185 Pages
From
The World Market for Molecular Diagnostics, 7th Edition (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases) - Product Thumbnail Image

The World Market for Molecular Diagnostics, 7th Edition (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases)

  • Report
  • 353 Pages
From
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) - Product Thumbnail Image

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

  • Report
  • 880 Pages
From
Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021 - Product Thumbnail Image

Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021

  • Report
  • 146 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations - Product Thumbnail Image

Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations

  • Report
  • 63 Pages
From
DNA Diagnostics Market: Technology, Microarrays, Lab-on-chip or biochips, In situ hybridization, Novel gene sequencing, Mass spectrometry, By Application - Forecast 2016-2021 - Product Thumbnail Image

DNA Diagnostics Market: Technology, Microarrays, Lab-on-chip or biochips, In situ hybridization, Novel gene sequencing, Mass spectrometry, By Application - Forecast 2016-2021

  • Report
  • 141 Pages
From
Allergic Conjunctivitis Market: By Disease Type, By Treatment Type & Geography - Forecast 2016-2021 - Product Thumbnail Image

Allergic Conjunctivitis Market: By Disease Type, By Treatment Type & Geography - Forecast 2016-2021

  • Report
  • 165 Pages
From
Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers - Product Thumbnail Image

Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers

  • Report
  • 155 Pages
From
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market - Product Thumbnail Image

Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market

  • Report
  • 131 Pages
From
Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Drug Pipelines
  • 682 Pages
From
Iressa - Gefitinib - Oncology Drug Report - 2002-2015 Analysis; 2016-2021 Expectations - Product Thumbnail Image

Iressa - Gefitinib - Oncology Drug Report - 2002-2015 Analysis; 2016-2021 Expectations

  • Report
  • 42 Pages
From
Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)], By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022 - Product Thumbnail Image

Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)], By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022

  • Report
  • 230 Pages
From
Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase Lyk or ITK or EC 2.7.10.2) - Pipeline Review, H2 2017 - Product Thumbnail Image

Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase Lyk or ITK or EC 2.7.10.2) - Pipeline Review, H2 2017

  • Report
  • 55 Pages
From
Loading Indicator
adroll